Orthocell Recruits First Patient for Ortho-ATI Shoulder Tendon Study

The first patient is recruited in a randomized, controlled clinical trial of Autologous Tenocyte Injection (Ortho-ATI®) vs. corticosteroid injection to treat rotator cuff tendinopathy. The trial is a collaboration between Orthocell and DePuy Synthes Products.

In previous studies, Ortho-ATI has been shown to be a cost effective, durable,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us